Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Itraconazole on BMS-986256 Pharmacokinetics
NCT03950960Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of afimetoran in systemic lupus erythematosus (SLE), sponsored by Bristol Myers Squibb. Primary endpoints: Maximum Observed Plasma Concentration at Day 29, Area Under the Plasma Concentration-time Curve from Time Zero to Time of Last Quantifiable Concentration at Day 29 and 1 more. Started May 2019; status: completed.
02
Drugs
afimetoran
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03950960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03950960.